Gyre Therapeutics' stock is volatile - I'm upholding my "Hold" rating due to uncertain long-term prospects and potential dilution from future funding needs. The company's products include Etuary ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Get Free Report)’s stock price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement.The stock had previously ...

In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on Gyre Therapeutics (GYRE – Research Report), with a price target of $20.00. The company’s shares ...

Earnings per share (EPS) missed analyst estimates by 71%. In the last 12 months, the only revenue segment was Gyre Pharmaceuticals contributing US$105.8m. The largest operating expense was Sales ...

Lee este artículo en español. If you love great deals, fast shipping, and streaming movies and music, an Amazon Prime membership might be perfect for you. From electronics, digital entertainment, to ...

Advert Who doesn't miss seeing these three muck about? (Prime Video) Hammond said it would be 'lovely' if the show carried on, but Clarkson was more particular about some boxes that needed to be ...

Gyre Therapeutics, Inc. (NASDAQ:GYRE – Free Report) – Stock analysts at Noble Financial issued their FY2024 earnings per share (EPS) estimates for Gyre Therapeutics in a research report issued ...

Prime Video’s top 10 includes a mix of fresh hits, fan favorites, and some that might not live up to the hype. Of course, the action-thriller “Reacher” remains the undisputed No. 1 after its ...

Award-winning distillery Gyre & Gimble has announced the launch of Curious Whiskies, an exclusive collection of single cask bottlings and an Islay peated blend, to celebrate the very best of Scotch ...